Poly Medicure Limited (NSE:POLYMED)
India · Delayed Price · Currency is INR 1,759.60
+26.60 (1.53%)
Aug 31, 2026, 3:30 PM IST
Poly Medicure Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 19,974 | 18,753 | 16,698 | 13,758 | 11,152 | 9,231 |
Revenue Growth | 18.31% | 12.30% | 21.37% | 23.36% | 20.82% | 17.37% |
Gross Profit Gross Profit Growth | 13,881 | 12,723 | 11,103 | 8,891 | 7,062 | 5,724 |
Operating Income Operating Income Growth | 3,328 | 3,290 | 3,716 | 2,963 | 2,128 | 1,596 |
Net Income Net Income Growth | 3,151 | 3,221 | 3,386 | 2,583 | 1,793 | 1,465 |
Earnings Per Share EPS Growth | 31.06 | 31.75 | 34.11 | 26.90 | 18.67 | 15.27 |
EPS Growth | -12.60% | -6.92% | 26.80% | 44.08% | 22.27% | 0.20% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 5,793 | 4,841 | 4,077 | 3,440 | 3,035 |
Europe Europe Growth | 4,927 | 5,383 | - | - | - |
Americas Americas Growth | 2,825 | 2,870 | - | - | - |
Asia Asia Growth | 2,335 | 2,015 | - | - | - |
Africa Africa Growth | 480.07 | 484.99 | - | - | - |
Others Others Growth | 106.6 | 274.55 | - | - | - |
Total Total Growth | 16,467 | 15,870 | 13,758 | 11,152 | 9,169 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 8,270 | 8,265 | 12,067 | 2,860 | 3,013 | 3,517 |
Total Debt Total Debt Growth | 3,536 | 3,536 | 1,802 | 1,739 | 1,490 | 1,267 |
Net Cash (Debt) Net Cash Growth | 4,735 | 4,730 | 10,264 | 1,121 | 1,523 | 2,250 |
Net Cash Growth | -53.93% | -53.92% | 815.78% | -26.39% | -32.31% | -5.02% |
Net Cash Per Share Net Cash Per Share Growth | 46.67 | 46.62 | 103.42 | 11.67 | 15.86 | 23.44 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 2,464 | 2,330 | 2,661 | 1,911 | 1,235 |
Capital Expenditures CapEx Growth | - | -3,084 | -3,310 | -2,770 | -2,393 | -1,556 |
Free Cash Flow Free Cash Flow Growth | - | -620.17 | -979.76 | -109.34 | -482.23 | -321.06 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 69.49% | 67.84% | 66.49% | 64.63% | 63.32% | 62.02% |
Operating Margin | 16.66% | 17.55% | 22.25% | 21.54% | 19.08% | 17.29% |
Pretax Margin | 21.12% | 22.80% | 27.10% | 25.02% | 21.30% | 21.15% |
Profit Margin | 15.77% | 17.18% | 20.28% | 18.77% | 16.08% | 15.87% |
FCF Margin | - | -3.31% | -5.87% | -0.80% | -4.32% | -3.48% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 1, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 3.500 | 3.500 | 3.500 | 3.000 | 3.000 | 2.500 |
Dividend Per Share Growth | 0% | 0% | 16.67% | 0% | 20.00% | 0% |
Dividend Yield | 0.20% | 0.29% | 0.16% | 0.19% | 0.32% | 0.27% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 1, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 56.72 | 37.47 | 67.10 | 59.04 | 51.01 | 62.11 |
PS Ratio | 8.95 | 6.44 | 13.61 | 11.08 | 8.20 | 9.86 |